TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MDXG

MiMedx Group Inc

Healthcare · Biotechnology

4.80$ +1.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement MDXG
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
10.7% 10.8% 13.2% 11.0% 10.1% 10.1% 15.8% 16.4% 18.0% 17.0% 17.2% 17.4%
89.3% 89.2% 86.8% 89.0% 89.9% 89.9% 84.2% 83.6% 82.0% 83.0% 82.8% 82.6%
6.0% 4.5% 5.9% 5.6% 4.4% 4.4% 4.7% 4.1% 4.7% 3.9% 3.5% 3.6%
76.5% 71.2% 69.4% 67.3% 70.3% 70.3% 72.9% 82.0% 78.0% 64.3% 64.5% 63.6%
83.3% 76.2% 78.1% 74.6% 91.0% 91.0% 102.4% 86.5% 87.5% 71.5% 65.9% 67.2%
6.0% 13.0% 0.4% 14.4% -1.1% -1.1% -18.3% -2.9% -5.5% 11.5% 16.9% 15.3%
0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 3.2% 2.1% 1.9% 2.0% 0.3% 0.4%
6.0% 13.0% 0.2% 14.0% -0.9% -0.9% -24.8% -5.0% -7.4% 9.5% 16.4% 15.8%
0.7% -2.8% 2.5% -6.1% 7.4% 7.4% -4.9% 0.1% 0.1% -11.4% 4.4% 4.2%
5.3% 15.7% 4.9% 20.2% -8.3% -8.3% -19.9% -5.1% -11.3% 21.0% 12.2% 11.6%
7.8% 14.5% 3.6% 16.4% 0.8% 4.9% -15.1% -0.8% -4.0% 12.6% 18.7% 19.8%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?